title: Three questions for evidence-based cardiac electrophysiology.
authors.affiliation: CardioVascular Institute, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA. dkramer@bidmc.harvard.edu
authors.forename: Daniel B
authors.initials: DB
authors.lastname: Kramer
authors.forename: Mark E
authors.initials: ME
authors.lastname: Josephson
mesh_terms: D000572:American Heart Association; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D001145:Arrhythmias, Cardiac / Q000175:diagnosis / Q000453:epidemiology / Q000503:physiopathology / Q000628:therapy*; D054849:Cardiac Electrophysiology; D058406:Cardiac Resynchronization Therapy; D009202:Cardiomyopathies / Q000175:diagnosis / Q000453:epidemiology / Q000503:physiopathology / Q000628:therapy*; D002986:Clinical Trials as Topic; D000075202:Contraindications; D019317:Evidence-Based Medicine; D054143:Heart Failure, Systolic / Q000175:diagnosis / Q000453:epidemiology / Q000503:physiopathology / Q000628:therapy*; D006801:Humans; D018579:Patient Selection; D017410:Practice Guidelines as Topic; D057285:Precision Medicine; D011787:Quality of Health Care; D014481:United States
chemical_list: D000889:Anti-Arrhythmia Agents